Advertisement
Screener

ClearPoint Neuro, Inc. (CLPT) Increase (Decrease) in Contract with Customer, Liability

ClearPoint Neuro, Inc. Increase (Decrease) in Contract with Customer, Liability

ClearPoint Neuro, Inc. (CLPT) reported Increase (Decrease) in Contract with Customer, Liability of $103.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInContractWithCustomerLiability · last filed 2026-08-03

  • ClearPoint Neuro, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2026-06-30 was -$69.00K, a 1480.00% decline year-over-year.
  • ClearPoint Neuro, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2026-03-31 was $172.00K.
  • ClearPoint Neuro, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2025-12-31 was -$250.00K, a 130.30% decline year-over-year.
  • ClearPoint Neuro, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2025-09-30 was $507.00K, a 144.93% increase year-over-year.
  • ClearPoint Neuro, Inc. increase (decrease) in contract with customer, liability for fiscal 2025 was -$319.00K.
  • ClearPoint Neuro, Inc. increase (decrease) in contract with customer, liability for fiscal 2024 was -$597.00K.
Period endIncrease (Decrease) in Contract with Customer, Liability 3 monthIncrease (Decrease) in Contract with Customer, Liability 6 monthIncrease (Decrease) in Contract with Customer, Liability 9 monthIncrease (Decrease) in Contract with Customer, Liability 12 month
2026-06-30-$69.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03
$103.00K
10-Q · filed 2026-08-03
-$147.00K
derived: sum of 3 quarters · filed 2026-08-03
$360.00K
derived: sum of 4 quarters · filed 2026-08-03
2026-03-31$172.00K
10-Q · filed 2026-05-13
-$78.00K
derived: sum of 2 quarters · filed 2026-05-13
$429.00K
derived: sum of 3 quarters · filed 2026-05-13
$434.00K
derived: sum of 4 quarters · filed 2026-08-03
2025-12-31-$250.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17
$257.00K
derived: sum of 2 quarters · filed 2026-03-17
$262.00K
derived: sum of 3 quarters · filed 2026-08-03
-$319.00K
10-K · filed 2026-03-17
2025-09-30$507.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
$512.00K
derived: sum of 2 quarters · filed 2026-08-03
-$69.00K
10-Q · filed 2025-11-06
$756.00K
derived: sum of 4 quarters · filed 2026-08-03
2025-06-30$5.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03
-$576.00K
10-Q · filed 2026-08-03
$249.00K
derived: sum of 3 quarters · filed 2026-08-03
$456.00K
derived: sum of 4 quarters · filed 2026-08-03
2025-03-31-$581.00K
10-Q · filed 2026-05-13
$244.00K
derived: sum of 2 quarters · filed 2026-05-13
$451.00K
derived: sum of 3 quarters · filed 2026-05-13
$286.00K
derived: sum of 4 quarters · filed 2026-05-13
2024-12-31$825.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17
$1.03M
derived: sum of 2 quarters · filed 2026-03-17
$867.00K
derived: sum of 3 quarters · filed 2026-03-17
-$597.00K
10-K · filed 2026-03-17
2024-09-30$207.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
$42.00K
derived: sum of 2 quarters · filed 2025-11-06
-$1.42M
10-Q · filed 2025-11-06
2024-06-30-$165.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12
-$1.63M
10-Q · filed 2025-08-12
2024-03-31-$1.46M
10-Q · filed 2025-05-13

Similar stocks

Stock NameCountryMarket CapPE Ratio
Sight Sciences, Inc. (SGHT)United States$0.478B-9.95
NeuroPace Inc (NPCE)United States$0.480B-28.52
CARLSMED, INC. (CARL)United States$0.405B
Orthofix Medical Inc. (OFIX)$0.373B
TACTILE SYSTEMS TECHNOLOGY INC (TCMD)United States$0.519B27.16
CERUS CORP (CERS)United States$0.525B-86.40
Orchestra BioMed Holdings, Inc. (OBIO)United States$0.356B-4.39
SHOULDER INNOVATIONS, INC. (SI)United States$0.355B
DELCATH SYSTEMS, INC. (DCTH)United States$0.558B820.33
Embecta Corp. (EMBC)United States$0.319B2.10